A recent study focused on Usp9X in the context of a frequent prostate carcinoma-related genetic translocation (TMPRSS2-ERG) [34] that facilitates tumor growth and thus not only represents a diagnostic aid, but also a potential therapeutic target. Here, USP9X is linked to neoplasm.